These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 7666550

  • 1. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
    Campbell S, Vogt VM.
    J Virol; 1995 Oct; 69(10):6487-97. PubMed ID: 7666550
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Proteolytic activity of purified avian sarcoma and leukemia virus NC-PR protein expressed in Escherichia coli.
    Séllos-Moura M, Vogt VM.
    Virology; 1996 Jul 15; 221(2):335-45. PubMed ID: 8661444
    [Abstract] [Full Text] [Related]

  • 4. Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli.
    Joshi SM, Vogt VM.
    J Virol; 2000 Nov 15; 74(21):10260-8. PubMed ID: 11024160
    [Abstract] [Full Text] [Related]

  • 5. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus.
    Gross I, Hohenberg H, Kräusslich HG.
    Eur J Biochem; 1997 Oct 15; 249(2):592-600. PubMed ID: 9370371
    [Abstract] [Full Text] [Related]

  • 6. The Structure of Immature Virus-Like Rous Sarcoma Virus Gag Particles Reveals a Structural Role for the p10 Domain in Assembly.
    Schur FK, Dick RA, Hagen WJ, Vogt VM, Briggs JA.
    J Virol; 2015 Oct 15; 89(20):10294-302. PubMed ID: 26223638
    [Abstract] [Full Text] [Related]

  • 7. Characterization of Rous sarcoma virus Gag particles assembled in vitro.
    Yu F, Joshi SM, Ma YM, Kingston RL, Simon MN, Vogt VM.
    J Virol; 2001 Mar 15; 75(6):2753-64. PubMed ID: 11222698
    [Abstract] [Full Text] [Related]

  • 8. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.
    Berkowitz RD, Luban J, Goff SP.
    J Virol; 1993 Dec 15; 67(12):7190-200. PubMed ID: 8230441
    [Abstract] [Full Text] [Related]

  • 9. In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.
    Campbell S, Vogt VM.
    J Virol; 1997 Jun 15; 71(6):4425-35. PubMed ID: 9151833
    [Abstract] [Full Text] [Related]

  • 10. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
    Rye-McCurdy TD, Nadaraia-Hoke S, Gudleski-O'Regan N, Flanagan JM, Parent LJ, Musier-Forsyth K.
    J Virol; 2014 Jul 15; 88(14):7852-61. PubMed ID: 24789780
    [Abstract] [Full Text] [Related]

  • 11. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.
    Wiegers K, Rutter G, Kottler H, Tessmer U, Hohenberg H, Kräusslich HG.
    J Virol; 1998 Apr 15; 72(4):2846-54. PubMed ID: 9525604
    [Abstract] [Full Text] [Related]

  • 12. The retroviral capsid domain dictates virion size, morphology, and coassembly of gag into virus-like particles.
    Ako-Adjei D, Johnson MC, Vogt VM.
    J Virol; 2005 Nov 15; 79(21):13463-72. PubMed ID: 16227267
    [Abstract] [Full Text] [Related]

  • 13. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation.
    Zhang Y, Barklis E.
    J Virol; 1995 Sep 15; 69(9):5716-22. PubMed ID: 7637017
    [Abstract] [Full Text] [Related]

  • 14. Hydrodynamic and Membrane Binding Properties of Purified Rous Sarcoma Virus Gag Protein.
    Dick RA, Datta SA, Nanda H, Fang X, Wen Y, Barros M, Wang YX, Rein A, Vogt VM.
    J Virol; 2015 Oct 15; 89(20):10371-82. PubMed ID: 26246573
    [Abstract] [Full Text] [Related]

  • 15. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.
    Campbell S, Rein A.
    J Virol; 1999 Mar 15; 73(3):2270-9. PubMed ID: 9971810
    [Abstract] [Full Text] [Related]

  • 16. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
    Poon DT, Li G, Aldovini A.
    J Virol; 1998 Mar 15; 72(3):1983-93. PubMed ID: 9499052
    [Abstract] [Full Text] [Related]

  • 17. In vitro assembly of human immunodeficiency virus type 1 Gag protein.
    Morikawa Y, Goto T, Sano K.
    J Biol Chem; 1999 Sep 24; 274(39):27997-8002. PubMed ID: 10488150
    [Abstract] [Full Text] [Related]

  • 18. Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding.
    Keller PW, Johnson MC, Vogt VM.
    J Virol; 2008 Jul 24; 82(14):6788-97. PubMed ID: 18448521
    [Abstract] [Full Text] [Related]

  • 19. Analysis of Rous sarcoma virus Gag protein by mass spectrometry indicates trimming by host exopeptidase.
    Pepinsky RB, Papayannopoulos IA, Campbell S, Vogt VM.
    J Virol; 1996 May 24; 70(5):3313-8. PubMed ID: 8627817
    [Abstract] [Full Text] [Related]

  • 20. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo.
    Berkowitz RD, Ohagen A, Höglund S, Goff SP.
    J Virol; 1995 Oct 24; 69(10):6445-56. PubMed ID: 7666546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.